Prevalence of Medically Resistant Epilepsy in Saudi Arabia

Abstract

<b><i>Objectives:</i></b> The objective of this study was to evaluate the prevalence of medically resistant epilepsy (MRE) in our hospital and to compare the prevalence with that in other populations. <b><i>Methods:</i></b> We retrospectively analyzed the data of patients who visited the epilepsy clinics at King Fahd University Hospital, Al-Khobar, Saudi Arabia between January 2017 and December 2018. This study included patients aged ≥14 years who had at least 2 unprovoked seizures 24 h apart. Patients who had provoked seizure(s), paroxysmal events, or syncope or had incomplete medical records were excluded. The definition and classification of the International League Against Epilepsy were used. Moreover, we searched the En­glish literature using PubMed and Google Scholar to compare the prevalence of MRE between our population and other populations. <b><i>Results:</i></b> In total, 1,151 patients were screened, and 751 patients were included in the final analysis. Of the 751 patients, 229 (male: 56.3%, female: 43.7%; mean age: 32.07 years, and standard deviation, 12.2 years) had MRE, with a cumulative prevalence of 30%. The etiology was as follows: unknown, 63.3% (<i>n</i> = 145); structural, 31.9% (<i>n</i> = 73); genetic, 3.1% (<i>n</i> = 7); and infectious, 1.7% (<i>n</i> = 4). None of the patients had metabolic or immune-related etiologies. <b><i>Conclusion:</i></b> The prevalence of MRE in our population (30%) is close to that in other populations (30–36.5%). Early identification of such patients is crucial to improve their management.